Frontiers in oncology

Front Oncol · ISSN (print) 2234-943X · 363 papers in corpus
other 2026
doi:10.3389/fonc.2026.1867620 ·PMID:42428145

[This corrects the article DOI: 10.3389/fonc.2022.859510.].

case-report 2026
doi:10.3389/fonc.2026.1815298 ·PMID:42222411

Pelvic ectopic kidney is a rare congenital anomaly, occurring in approximately 0.1% of the adult population, and is often asymptomatic. However, it can easily be mistaken for a pelvic tumor or lymph-node metastasis. This case report details…

observational 2026
doi:10.3389/fonc.2026.1934729 ·PMID:42740953

INTRODUCTION: Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy, and accurate prediction of long-term survival remains challenging. This study aimed to evaluate the prognostic associations of prespecified clin…

diagnostic-accuracy 2026
doi:10.3389/fonc.2026.1914278 ·PMID:42952826

​​backgroundUltrasound-based risk models provide a valuable tool to support non-expert clinicians in evaluating adnexal masses, potentially reducing unnecessary surgeries for benign conditions. However, their implementation in clinical prac…

diagnostic-accuracy 2026
doi:10.3389/fonc.2026.1758644 ·PMID:41924594

BACKGROUNDS: The preoperative differentiation of borderline ovarian epithelial tumors (BOETs) remains challenging. While systemic inflammatory markers such as the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and…

lab-animal 2026
doi:10.3389/fonc.2026.1760903 ·PMID:41695330

INTRODUCTION: Endometrial cancer has the highest incidence among gynecologic malignancies, with a global prevalence of 10-20%. Type II tumors are generally high-grade and recurrent. Combination chemotherapy can provide synergistic effects t…

review 2026
doi:10.3389/fonc.2026.1876327 ·PMID:42621564

Ovarian cancer is the deadliest gynecologic cancer in individuals assigned female at birth. Patients diagnosed with ovarian cancer experience poor survival rates due to frequent late-stage diagnosis and aggressive metastases. Ovarian cancer…

case-report 2026
doi:10.3389/fonc.2026.1846023 ·PMID:42344689

BACKGROUND: Endometriosis is common in reproductive-age women, but the development of an endometriotic cyst that mimics tumor recurrence during follow-up after treatment for ovarian immature teratoma poses a significant diagnostic challenge…

observational 2026
doi:10.3389/fonc.2026.1842401 ·PMID:42819043

BACKGROUND: Postoperative recovery and venous thromboembolism (VTE) are major concerns following total laparoscopic hysterectomy (TLH). This study aimed to evaluate the impact of a multimodal prehabilitation program on postoperative recover…

case-report 2026
doi:10.3389/fonc.2026.1808753 ·PMID:42245742

Intravascular papillary endothelial hyperplasia (IPEH) is a rare vascular lesion that can histologically mimic malignant vascular tumors, particularly angiosarcoma, often leading to misdiagnosis and overtreatment. IPEH involving the uterine…

case-report 2026
doi:10.3389/fonc.2026.1837994 ·PMID:42952678

BACKGROUND: The malignant transformation of endometriosis has garnered widespread attention; however, most cases of malignant transformation occur in ovarian endometriomas, while extraovarian malignant transformation is rare. We present an …

case-report 2026
doi:10.3389/fonc.2026.1865870 ·PMID:42388624

BACKGROUND: Endometriosis is a prevalent benign condition among women of reproductive age. While the overall rate of endometriosis-associated malignancy is low, the risk of malignant transformation increases significantly in postmenopausal …

case-report 2026
doi:10.3389/fonc.2026.1828586 ·PMID:42326327

INTRODUCTION: We report an unexpected case of mesonephric-like adenocarcinoma initially treated as a diffuse adenomyosis in a patient presenting with primary infertility. The aim of this report is to raise clinical awareness about the risk …

review 2026
doi:10.3389/fonc.2026.1787691 ·PMID:42245728

MicroRNA-17(miR-17) is a prototypical oncogenic miRNA that plays a central driving role in the initiation and progression of various malignant tumours (MT), including lymphoma, lung cancer, colorectal cancer (CRC), and breast cancer (BC). I…

other 2026
doi:10.3389/fonc.2026.1839124 ·PMID:42318485
case-report 2026
doi:10.3389/fonc.2026.1945284 ·PMID:42723985

BACKGROUND: Malignant transformation of endometriosis is rare and most commonly involves the ovary. Extraovarian transformation, particularly in the gastrointestinal tract, is exceptional, and clear cell carcinoma (CCC) arising from intesti…

case-report 2026
doi:10.3389/fonc.2026.1760937 ·PMID:42078805

Gastric metastasis from breast cancer (GMBC) is a rare but diagnostically challenging condition, whose clinical and imaging features often mimic primary gastric cancer or treatment-related adverse effects. This study integrates a detailed c…

case-report 2026
doi:10.3389/fonc.2026.1846804 ·PMID:42553266

BACKGROUND: Carbohydrate antigen 19-9 (CA19-9) is a well-established tumour marker primarily associated with pancreaticobiliary and gastrointestinal malignancies. Its elevation in benign gynaecological conditions, particularly in isolated o…

case-report 2026
doi:10.3389/fonc.2026.1843939 ·PMID:42824185

BACKGROUND: Aggressive Angiomyxoma (AAM) is a rare mesenchymal tumor characterized by local invasiveness and a high recurrence rate, often arising in the pelvis and perineum. CASE PRESENTATION: We report a 49-year-old woman presenting with…

review 2026
doi:10.3389/fonc.2026.1785469 ·PMID:42022325

INTRODUCTION: The clinical management of gynecologic malignancies endometrial (EC), ovarian (OC), and cervical (CC) carcinomas has been historically guided by histomorphology and staging. This paradigm fails to capture profound molecular he…

other 2026
doi:10.3389/fonc.2026.1886007 ·PMID:42745833

OBJECTIVE: To investigate the predictive value of preoperative serum markers centered on human epididymis protein 4 (HE4) combined with carbohydrate antigen 125 (CA125) for the risk of suboptimal cytoreduction in advanced epithelial ovarian…

other 2026
doi:10.3389/fonc.2026.1769442 ·PMID:42130637

BACKGROUND: Ovarian and endometrial cancers together account for nearly 10% of all female cancer-related deaths worldwide, with ovarian cancer being the deadliest gynecologic malignancy. We aimed to evaluate the diagnostic performance of ge…

other 2026
doi:10.3389/fonc.2026.1674171 ·PMID:41695346

OBJECTIVE: To assess the safety and efficacy of percutaneous intrauterine hydrodissection as a protective technique during microwave ablation (MWA) of uterine fibroids adjacent to the endometrium. MATERIALS AND METHODS: A retrospective ana…

other 2026
doi:10.3389/fonc.2026.1839127 ·PMID:42255234

BACKGROUND: Molecular characterization of epithelial ovarian cancer has been conducted predominantly in populations of European ancestry, leaving Latin American populations significantly underrepresented. Colombian patients, characterized b…

observational 2026
doi:10.3389/fonc.2026.1810193 ·PMID:42022310

BACKGROUND: The need for complete staging surgery including hysterectomy for all age patients with borderline ovarian tumors (BOT) is debatable, considering fertility in younger patients and potential higher morbidity in older patients. We …